Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(3.68)
# 834
Out of 4,734 analysts
73
Total ratings
34.25%
Success rate
13.03%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGON CG Oncology | Reiterates: Buy | $75 | $30.00 | +150.00% | 10 | Jan 10, 2025 | |
| ENGN enGene Holdings | Initiates: Buy | $25 | $6.97 | +258.68% | 1 | Dec 23, 2024 | |
| SRRK Scholar Rock Holding | Maintains: Buy | $40 → $50 | $44.88 | +11.41% | 13 | Nov 26, 2024 | |
| HOWL Werewolf Therapeutics | Reiterates: Buy | $15 | $1.36 | +1,002.94% | 15 | Nov 19, 2024 | |
| MURA Mural Oncology | Reiterates: Buy | $18 | $4.14 | +334.78% | 3 | Nov 14, 2024 | |
| ERAS Erasca | Reiterates: Buy | $6 | $1.90 | +215.79% | 8 | Nov 13, 2024 | |
| IKNA Ikena Oncology | Reiterates: Buy | $4 | $1.52 | +163.16% | 11 | Nov 11, 2024 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $40 | $12.24 | +226.80% | 12 | Oct 31, 2024 |
CG Oncology
Jan 10, 2025
Reiterates: Buy
Price Target: $75
Current: $30.00
Upside: +150.00%
enGene Holdings
Dec 23, 2024
Initiates: Buy
Price Target: $25
Current: $6.97
Upside: +258.68%
Scholar Rock Holding
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $44.88
Upside: +11.41%
Werewolf Therapeutics
Nov 19, 2024
Reiterates: Buy
Price Target: $15
Current: $1.36
Upside: +1,002.94%
Mural Oncology
Nov 14, 2024
Reiterates: Buy
Price Target: $18
Current: $4.14
Upside: +334.78%
Erasca
Nov 13, 2024
Reiterates: Buy
Price Target: $6
Current: $1.90
Upside: +215.79%
Ikena Oncology
Nov 11, 2024
Reiterates: Buy
Price Target: $4
Current: $1.52
Upside: +163.16%
Day One Biopharmaceuticals
Oct 31, 2024
Reiterates: Buy
Price Target: $40
Current: $12.24
Upside: +226.80%